Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
Cancer
|
September 13, 2007
Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer
Giridhar Mudduluru, Fabian Medved, Rainer Grobholz, et al.
Trials
|
August 31, 2012
DeloRes trial: study protocol for a randomized trial comparing two standardized surgical approaches in rectal prolapse - Delorme's procedure versus resection rectopexy
Simone Rothenhoefer, Florian Herrle, Alexander Herold, et al.
Onkologie
|
September 15, 2010
Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?
Karoline Horisberger, Philipp Erben, Philipp Ströbel, et al.
Journal of Gastroenterology
|
March 18, 2016
Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications
Djeda Belharazem, Julia Magdeburg, Ann-Kristin Berton, et al.
Anti-Cancer Drugs
|
May 14, 2009
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer
Karoline Horisberger, Philipp Erben, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 10, 2008
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial
Ralf-Dieter Hofheinz, Frederik Wenz, Nadine Lukan, et al.
Gastroenterology Research and Practice
|
September 10, 2016
Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer
Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, et al.
Annals of Surgery
|
March 28, 2013
Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas
Marius Distler, Stephan Kersting, Marco Niedergethmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2005
Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer
Ralf-Dieter Hofheinz, Bolko von Gerstenberg-Helldorf, Frederik Wenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2007
Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer
Gabriele D Maurer, Joerg H Leupold, Denis M Schewe, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
Cancer
|
September 13, 2007
Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer
Giridhar Mudduluru, Fabian Medved, Rainer Grobholz, et al.
Trials
|
August 31, 2012
DeloRes trial: study protocol for a randomized trial comparing two standardized surgical approaches in rectal prolapse - Delorme's procedure versus resection rectopexy
Simone Rothenhoefer, Florian Herrle, Alexander Herold, et al.
Onkologie
|
September 15, 2010
Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy?
Karoline Horisberger, Philipp Erben, Philipp Ströbel, et al.
Journal of Gastroenterology
|
March 18, 2016
Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications
Djeda Belharazem, Julia Magdeburg, Ann-Kristin Berton, et al.
Anti-Cancer Drugs
|
May 14, 2009
Topoisomerase I expression correlates to response to neoadjuvant irinotecan-based chemoradiation in rectal cancer
Karoline Horisberger, Philipp Erben, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 10, 2008
Oxaliplatin and capecitabine-based chemoradiotherapy for gastric cancer--an extended phase I MARGIT and AIO trial
Ralf-Dieter Hofheinz, Frederik Wenz, Nadine Lukan, et al.
Gastroenterology Research and Practice
|
September 10, 2016
Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer
Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, et al.
Annals of Surgery
|
March 28, 2013
Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas
Marius Distler, Stephan Kersting, Marco Niedergethmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2005
Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer
Ralf-Dieter Hofheinz, Bolko von Gerstenberg-Helldorf, Frederik Wenz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2007
Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer
Gabriele D Maurer, Joerg H Leupold, Denis M Schewe, et al.
Page
of 14